Age: 25
Free Agency: 2024 (UFA)
Accrued Seasons: 3
- Height: 6'5"
- Weight: 275
- College: Iowa
- Entry: 2020 Draft, Round 2, #54 overall (Bills)
- 2023 Salary Cap Charge: $1,870,051 (0.82% of cap)
- 2023 Cash Payout: $1,411,450 (0.49% of spending)
- 2023 Cash to Cap Ratio: 0.75
- Contract Value: $5,877,304 ($1,469,326 APY)
- Fully Guaranteed Money: $3,321,554
- Contract Ranking: 94/248 at EDGE
Current Contract
(Drafted, signed 2020)
(📝: indicates contract trigger occuring during that year)Year | Age | Base Salary | Prorated Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2020 | 22 | $610,000 | $458,601 | $0 | $610,000 | $1,068,601 | 0.5% | |||||
2021 | 23 | $877,150 | $458,601 | $0 | $877,150 | $1,335,751 | 0.7% | |||||
2022 | 24 | $1,069,300 | $458,601 | $75,000 | $0 | $1,602,901 | 0.8% | |||||
2023 | 25 | $1,336,450 | $458,601 | $75,000 | $0 | $1,870,051 | 0.8% | |||||
Total | $3,892,900 | $1,834,404 | $150,000 | $1,487,150 | $5,877,304 |
Contract Notes
A.J. Epenesa signed a four year contract with the Bills on May 8, 2020 that is worth $5,877,304. Epenesa's guarantee is worth $3,321,554. The guarantee package is made up of his 2020 and 2021 base salaries as well as a signing bonus of $1,834,404. There are non-guaranteed $75,000 workout bonuses in the final two contract years.
Cash Flows
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Cash Due | $2,444,404 | $877,150 | $1,144,300 | $1,411,450 |
Running Cash | $2,444,404 | $3,321,554 | $4,465,854 | $5,877,304 |
Career Earnings: $4,465,854
Career APY: $1,488,618
Contract History
Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
---|---|---|---|---|---|---|---|---|---|---|
Bills | Drafted | Active | 2020 | 4 | $5,877,304 | $1,469,326 | $3,321,554 | $4,465,854 | 76.0% | $1,488,618 |
Earnings By Team
Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
---|---|---|---|---|---|---|---|
Bills | 3 | $4,465,854 | $1,488,618 | $4,007,253 | 0.0% | $0 | 0.0% |
Season History
Year | Team | Base Salary | Prorated Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
---|---|---|---|---|---|---|---|---|---|---|
2020 | Bills | $610,000 | $458,601 | $0 | $610,000 | $1,068,601 | 0.5% | $2,444,404 | ||
2021 | Bills | $877,150 | $458,601 | $0 | $877,150 | $1,335,751 | 0.7% | $877,150 | ||
2022 | Bills | $1,069,300 | $458,601 | $75,000 | $0 | $1,602,901 | 0.8% | $1,144,300 | ||
2023 | Bills | $1,336,450 | $458,601 | $75,000 | $0 | $1,870,051 | 0.8% | $1,411,450 | ||
Total | $3,892,900 | $1,834,404 | $150,000 | $1,487,150 | $5,877,304 | $5,877,304 |
Statistics
Year | Games Played | Games Inactive | Snaps | Tackles | Negative Plays | Interceptions | Fumbles | TD | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Injured | Healthy | Defense | Special | Solo | Assist | Sacks | Yards | TFL | QB Hits | Pass Def. | INT | Yards | Forced | Rec. | Yards | |||
2020 | 14 | 0 | 2 | 27.2% | 17.8% | 11 | 3 | 1 | 2 | 3 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
2021 | 14 | 1 | 1 | 30.6% | 33.2% | 8 | 6 | 1.5 | 13 | 2 | 9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
2022 | 15 | 0 | 1 | 35.7% | 10.5% | 13 | 3 | 6.5 | 56.5 | 7 | 10 | 5 | 0 | 0 | 2 | 1 | 0 | 0 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
OTC Valuation | APY | |
---|---|---|
Regular | $2,482,000 | $1,469,326 |
Injury Adjusted | $2,482,000 | $1,469,326 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.